BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12410702)

  • 21. Topical nitrogen mustard therapy in patients with Langerhans cell histiocytosis.
    Lindahl LM; Fenger-Grøn M; Iversen L
    Br J Dermatol; 2012 Mar; 166(3):642-5. PubMed ID: 21967132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PUVA therapy prevents sensitization to mechlorethamine in patients with psoriasis.
    Mauduit G; Silvestre O; Thivolet J
    Br J Dermatol; 1985 Nov; 113(5):515-21. PubMed ID: 2933055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Elderly Man With New Skin Plaques Consistent With Cutaneous T-Cell Lymphoma.
    Rubio-González B; Zain J; Rosen ST; Querfeld C
    Oncology (Williston Park); 2016 Oct; 30(10):908-13. PubMed ID: 27744647
    [No Abstract]   [Full Text] [Related]  

  • 24. Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.
    Querfeld C; Scarisbrick JJ; Assaf C; Guenova E; Bagot M; Ortiz-Romero PL; Quaglino P; Bonizzoni E; Hodak E
    Dermatology; 2022; 238(2):347-357. PubMed ID: 34091453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma.
    Dulmage BO; Story SK; Falo LD; Geskin LJ
    Leuk Lymphoma; 2015 Jul; 56(7):2225-7. PubMed ID: 25511681
    [No Abstract]   [Full Text] [Related]  

  • 26. Stability of the nitrogen mustard mechlorethamine in novel formulations for dermatological use.
    Ritschel WA; Ye W; Buhse L; Reepmeyer JC
    Int J Pharm; 2008 Oct; 362(1-2):67-73. PubMed ID: 18634862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contact urticaria and anaphylactic reactions induced by topical application of nitrogen mustard].
    Sánchez Yus E; Surárez Martín E
    Actas Dermosifiliogr; 1977; 68(12):39-44. PubMed ID: 140594
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous T cell lymphoma: update of treatment.
    Zackheim HS
    Dermatology; 1999; 199(2):102-5. PubMed ID: 10559573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Local treatments of cutaneous T-cell lymphomas].
    Bachelez H
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S23-6. PubMed ID: 16385895
    [No Abstract]   [Full Text] [Related]  

  • 30. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stevens-Johnson syndrome associated with topical nitrogen mustard therapy.
    Newman JM; Rindler JM; Bergfeld WF; Brydon JK
    J Am Acad Dermatol; 1997 Jan; 36(1):112-4. PubMed ID: 8996276
    [No Abstract]   [Full Text] [Related]  

  • 32. Ointment-based mechlorethamine treatment for mycosis fungoides.
    Price NM; Hoppe RT; Deneau DG
    Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy.
    Price NM; Hoppe RT; Constantine VS; Fuks ZY; Farber EM
    Cancer; 1977 Dec; 40(6):2851-3. PubMed ID: 412580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the Treatment Patterns of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: By-time Reanalysis of a Randomized Controlled Phase 2 Study.
    Geskin LJ; Kim EJ; Angello JT; Kim YH
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):119-124.e4. PubMed ID: 33358692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Melanoma and dysplastic nevus after 8 years of topical Caryolysine].
    Cosnes A; Revuz J; Wechsler J; Touraine R
    Ann Dermatol Venereol; 1984; 111(2):127-32. PubMed ID: 6721359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis therapy. The effect of UV radiation on sensitization to mechlorethamine.
    Nusbaum BP; Edwards EK; Horwitz SN; Frost P
    Arch Dermatol; 1983 Feb; 119(2):117-21. PubMed ID: 6337558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Necrotic leg ulcers after topical application of chlormethine].
    Gary C; Gautier V; Lazareth I; Bagot M; Asgari R; Priollet P
    Ann Dermatol Venereol; 2019 Mar; 146(3):226-231. PubMed ID: 30704945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
    Benjamin Chase A; Markel K; Tawa MC
    Clin J Oncol Nurs; 2015 Dec; 19(6):E131-9. PubMed ID: 26583648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.